Check out our wide range of fillers and injectables.
No products were found matching your selection.
Monovisc is an orthopedic injectable composed of non-animal sodium hyaluronate that is used to relieve pain in patients afflicted with knee osteoarthritis. Monovisc product is manufactured by Anika Therapeutics.
For individuals experiencing persistent joint pain due to knee osteoarthritis, finding the right solutions is essential for maintaining mobility and overall health. When first-line treatments like pain medications and physical therapy fail to provide sufficient pain relief, advanced options such as viscosupplementation may be recommended. These treatments help restore lubrication to the affected bones and joints, reducing discomfort and improving function.
While some patients opt for generic alternatives, consulting a doctor is crucial to determine the most effective treatment plan based on individual needs. As with any medical intervention, it is important to be aware of potential side effects, such as mild swelling or temporary stiffness, which should be discussed with a healthcare provider. By choosing the right treatment approach, patients can experience long-term pain relief and improved joint function, leading to a better quality of life.
For individuals suffering from osteoarthritis, knee injections like Monovisc offer an effective way to manage joint pain and improve mobility. Monovisc is a high-quality orthopaedic treatment designed to provide mechanical support and lubrication to affected joints, reducing discomfort and preventing further cartilage deterioration. Those looking to incorporate this therapy into their treatment plan can conveniently order Monovisc online from trusted supplies providers, ensuring easy access to this advanced pain management solution.
Monovisc is formulated as a highly viscous gel, mimicking the properties of healthy synovial fluid found in the bones and joints. By restoring the natural lubrication within the joint space, it minimizes friction, reduces inflammation, and slows down cartilage wear. This process helps patients regain mobility and maintain overall health while preventing further damage caused by osteoarthritis. With just a single injection, Monovisc delivers long-lasting relief, making it a preferred choice among orthopaedic professionals and patients alike.
This single-dose treatment ensures that the patient gains all the benefits of therapy in one session. The risk of infection and other procedure-related side-effects is also lowered with fewer injections.
Treatment with Monovisc product is ideal for those who have tried analgesic treatments and exercise to improve their condition but found these modalities inadequate. Monovisc can be combined with other osteoarthritis treatments to supplement the effects.
Additionally, the hyaluronic acid(HA) that Monovisc is composed of is of non-animal origin, which aids in reducing hypersensitivity.
The HA in Monovisc product is modified to give it the optimal biomechanical properties required to treat osteoarthritis effectively and to ensure long-lasting results (up to 6 months).
Monovisc is safe for use and is generally well-tolerated in clients suffering from osteoarthritis. It can be used together with other osteoarthritis treatments.
That being said, certain groups of patients should be excluded from Monovisc treatment, such as patients with known allergy to any of the components of Monovisc, active inflammation or infection at the intended injection site, bleeding disorders, who are receiving anticoagulant therapy, who are prone to keloid formation or hypertrophic scarring, who are pregnant or breastfeeding, and children under 18 years of age.
The Monovisc injection procedure does not result in any downtime, and patients can resume their daily activities right after the treatment.
Monovisc is an orthopedic injectable composed of non-animal sodium hyaluronate that is used to relieve pain in patients afflicted with knee osteoarthritis. Monovisc product is manufactured by Anika Therapeutics.
For individuals experiencing persistent joint pain due to knee osteoarthritis, finding the right solutions is essential for maintaining mobility and overall health. When first-line treatments like pain medications and physical therapy fail to provide sufficient pain relief, advanced options such as viscosupplementation may be recommended. These treatments help restore lubrication to the affected bones and joints, reducing discomfort and improving function.
While some patients opt for generic alternatives, consulting a doctor is crucial to determine the most effective treatment plan based on individual needs. As with any medical intervention, it is important to be aware of potential side effects, such as mild swelling or temporary stiffness, which should be discussed with a healthcare provider. By choosing the right treatment approach, patients can experience long-term pain relief and improved joint function, leading to a better quality of life.
For individuals suffering from osteoarthritis, knee injections like Monovisc offer an effective way to manage joint pain and improve mobility. Monovisc is a high-quality orthopaedic treatment designed to provide mechanical support and lubrication to affected joints, reducing discomfort and preventing further cartilage deterioration. Those looking to incorporate this therapy into their treatment plan can conveniently order Monovisc online from trusted supplies providers, ensuring easy access to this advanced pain management solution.
Monovisc is formulated as a highly viscous gel, mimicking the properties of healthy synovial fluid found in the bones and joints. By restoring the natural lubrication within the joint space, it minimizes friction, reduces inflammation, and slows down cartilage wear. This process helps patients regain mobility and maintain overall health while preventing further damage caused by osteoarthritis. With just a single injection, Monovisc delivers long-lasting relief, making it a preferred choice among orthopaedic professionals and patients alike.
This single-dose treatment ensures that the patient gains all the benefits of therapy in one session. The risk of infection and other procedure-related side-effects is also lowered with fewer injections.
Treatment with Monovisc product is ideal for those who have tried analgesic treatments and exercise to improve their condition but found these modalities inadequate. Monovisc can be combined with other osteoarthritis treatments to supplement the effects.
Additionally, the hyaluronic acid(HA) that Monovisc is composed of is of non-animal origin, which aids in reducing hypersensitivity.
The HA in Monovisc product is modified to give it the optimal biomechanical properties required to treat osteoarthritis effectively and to ensure long-lasting results (up to 6 months).
Monovisc is safe for use and is generally well-tolerated in clients suffering from osteoarthritis. It can be used together with other osteoarthritis treatments.
That being said, certain groups of patients should be excluded from Monovisc treatment, such as patients with known allergy to any of the components of Monovisc, active inflammation or infection at the intended injection site, bleeding disorders, who are receiving anticoagulant therapy, who are prone to keloid formation or hypertrophic scarring, who are pregnant or breastfeeding, and children under 18 years of age.
The Monovisc injection procedure does not result in any downtime, and patients can resume their daily activities right after the treatment.